Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNSS
DateTimeSourceHeadlineSymbolCompany
12/17/20198:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/06/20194:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/05/201911:41AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Data from Ongoing Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Ma...NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/12/20194:46PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/12/20194:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/12/20194:05PMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Third Quarter 2019 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
11/08/20197:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Present at 28th Annual Credit Suisse Healthcare ConferenceNASDAQ:SNSSSunesis Pharmaceuticals Inc
11/06/20199:16AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation at 61st American Society of Hematology Annual MeetingNASDAQ:SNSSSunesis Pharmaceuticals Inc
10/29/20197:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on November 12th to Discuss Third Quarter 2019 Financial Results and Recent H...NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/16/20194:59PMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 2019 AACR-NCI-EORTC International Conferenc...NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/01/20192:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
09/27/20195:14PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
09/19/20194:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
09/19/20197:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Appoints Dr. Nicole Onetto to the Board of DirectorsNASDAQ:SNSSSunesis Pharmaceuticals Inc
08/28/20197:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Present at the Wells Fargo Healthcare ConferenceNASDAQ:SNSSSunesis Pharmaceuticals Inc
08/12/20194:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/07/20194:34PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/07/20194:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/07/20194:05PMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Second Quarter 2019 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/31/20197:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on August 7th to Discuss Second Quarter 2019 Financial Results and Recent Hig...NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/22/20199:24AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/19/20194:02PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/15/20194:16PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/15/20194:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/12/20196:16AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/12/20196:12AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/12/20196:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/11/201912:30AMGlobeNewswire Inc.Sunesis Announces Pricing of $25 Million Offering of SecuritiesNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/10/20194:22PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/10/20194:21PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS

Your Recent History

Delayed Upgrade Clock